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ABSTRACT: During the courses of chemotherapeutic research of falciparum and vivax
malaria patients in a rural area, some biochemical examinations of blood and urine samples
were tried to carry out by using a portable electric generator, a digital blood analyser kit, and
a small D. C. power supply for electrophoresis. Comparisons were made between samples, as
a rule, just before starting radical treatments with chloroquine or other drugs and after
completion of two-weeks' follow-up. (1) Quantitative analyses were done for Hb, total protein,
albumin, GOT, GPT, LDH, blood urea nitrogen, zinc sulphate turbidity test, etc. Increased
levels in LDH, GOT and GPT, and decreased levels in total protein, albumin, and Hb were
noticed in both falciparum and vivax malaria patients before the drug treatment. (2) Results
of polyacrylamide gel electrophoresis showed an improvement (increase) of prealbumin level af-
ter the chemotherapy in almost all the patients. Decrease in an unidentified protein at post-
transferrin position was noticed after the cure of malaria in almost all the falciparum cases but
in about half of vivax cases. (3) Analysis of LDH isozyme patterns in plasma indicated that
severe hemolysis of the host RBC was mainly responsible for the elevated LDH levels in ma-
laria patients. Difficulty in assorting haptoglobin types for many malaria patients also support-
ed this explanation by severe hemolysis. (4) Remarkable improvements in urine protein and
urobilinogen levels were observed after the drug treatment, whereas no recognizable alteration
was found in pH, glucosuria, and bilirubin levels. (5) By thin-layer chromatography on pre-
coated silica gel plates, it was quite easy to detect antimalarial drugs extracted from urine
samples of patients at various intervals even one week after the oral administration, but the
detection of chloroquine from blood samples was not successful.
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Informations on blood protein and enzyme levels or their electrophoretic patterns of a
patient are quite useful for diagnosis in some diseases, and these techniques have now
become routine in most of clinical laboratories. With respect to the course of human malar-
ia, the infection may influence, either directly or indirectly, protein levels of patients, and
various investigators have reported such alterations in blood biochemical values as shown in
Table 1. Most of these works have been carried out under well-facilitated laboratory condi-
tions, and some cases involve results of even experimental infections of human malaria to
human volunteers or to other primates. Under the circumstances of field survey on malaria in
actual tropical zones, however, it is rather difficult to obtain necessary informations on the
clinical biochemistry in each patient before and after starting chemotherapy with an anti-
malarial drug. Therefore, the preliminary trials were attempted to carry out some clinical
blood examinations and plasma electrophoresis using a portable electric generator in a field
condition or in a poorly facilitated rural hospital.
T able 1. Reported alterations on serum (or plasma) biochemical levels due to
infections with human malaria
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* Splenectomized
The works reported here have been carried out in Palawan Island, the Philippines,
from October 1971 to January 1972, and from January to February 1973, by members of the
Nagasaki University Medical Research Team, in which the last author was the team leader,
in cooperation with members of the Malaria Eradication Service, Department of Health, Re-
public of the Philippines.
MATERIALS AND METHODS
Patients. All the out-patients who visited the General Hospital, Iwahig Penal Colony,
Palawan, were at first screened for malaria by examining blood smears during the period of
our survey. Patients (<?<?) confirmed microscopically to be infected with either Plasmodium
falciparum or P. vivax, were admitted into the hospital at the Central area or an infirmary
at the Montible area. A total of 118 patients consisting of 63 vivax, 49 falciparum, 2 malariae
cases and 4 of mixed infections (with P. vivax and P. falciparum} was treated with drugs
and was under the follow-up observations in the 1971-1972 survey. Patients who showed
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recrudescence were omitted from the test group. Among them 53 were subjected to the
biochemical blood examinations (23 falciparum cases and 30 vivax cases). In the 1973 sur-
vey, a total of 220 malaria patients (212 falciparum, 7 vivax, and 1 mixed cases) was treat-
ed, and 74 falciparum patients were subjected to the chemotherapeutic research.
Chemotherapy. Radical treatment with chloroquine diphosphate (Resochin or Aralen,
150 mg base/tablet) was carried out to the patients as previously reported by Nakabayashi
et aL (1974). Sulfamethopyrazine (Policydal, 100 mg/tablet) was also used, 800 mg at Day 0,
followed by each 100 mg for Day 1 to Day 4, alone or in combination with chloroquine. For
the convenience of explanation, a typical course of the drug treatment, follow-up, blood
smear examination, and biochemical examination was shown in Fig. 1.
Clinical Examination of Blood. The examinations were done as a rule twice for each
patient, i. e. , the first just before starting the drug treatment and the second after follow-up
observation when the parasite detection on thick blood smears continued submicroscopic at
least for two weeks.
Each 5 ml sample of blood was drawn from the cubital vein by using commercially
available vacuum blood collecting tubes which contain appropriate amounts of EDTA *2Na.
Particular cares were paid to avoid any artificial hemolysis during all the procedures. An
aliquot of blood was immediately examined for the hemoglobin (Hb) level. Plasma was then
separated from blood cells by a centrifugator and was kept in an ice-cold thermo bottle. An
aliquot of plasma was used for biochemical examinations within 2 hours and the rest was fur-
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Fig. 1. Chemotherapeutic course with chloroquine diphosphate in a falciparum
malarial case.
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ther kept in a kerosene-operated refrigerator until used for electrophoretic analysis. As a
control group, 10 healthy Filipinos who had no malarial experience at least for recent 5 years
were chosen.
A digital handy blood analyser (UNIKIT-RaBA system, Chugai Pharmaceutical Co. ,
Ltd.) connected with a portable electric generator (Honda, 300W, 100V) was used forthe
clinical-biochemical analysis. Chemical reagents to be used for this kit were kept at room
temperature (about 30°C in the day-time and about 20°C at night). The items tested were:
hemoglobin (Hb) , total protein (TP) , albumin (Alb) , aspartate aminotransferase (glutamate-
oxaloacetate transaminase , GOT) , alanine aminotransferase (glutamate-pyruvate transaminase ,
GPT), lactate dehydrogenase (LDH), blood urea nitrogen (BUN), leucine aminopeptidase
(LAP), alkaline phosphatase (AlkP), and zinc sulfate turbidity test (ZTT).
Clinical Examination of Urine. At the same time, urine of the patients was also ex-
amined by using a commercially available simple reagent strip (Hemacombistix, Ono Pharma-
ceutical Co., Ltd.) for pH, glucosuria, occult hematuria and proteinuria. In addition to
these items, handy color tests for urobilinogen and bilirubin (Sino test No. 5 and No. 6,
respectively, Sino-test Laboratory) were also employed.
Electrophoretic Analysis of Plasma. Horizontal electrophoresis on 5% polyacrylamide gel
plate was carried out to compare the patterns of plasma protein and some enzymes before and
after the chemotherapeutic course. The practical method employed was essentially same as
described by Tsukamoto (1974). The portable electric generator operated by kerosene was
connected to a small B. C. power supply directly or through a half-down transformer. Un-
der these conditions the voltage was usually within a range of 120-150V during the electro-
phoresis. The plasma samples to be examined were kept in a refrigerator except for the LDH
pattern analysis which was carried out with fresh samples within several hours after plasma
separation because LDH-5 and LDH-4 bands were less stable than other isoenzyme bands
during the storage.
After the electrophoretic run, proteins were simultaneously fixed and stained with
0.5% Amido black 10B in a mixture solution of methanol-water-acetic acid (5 : 4: 1, v/v),
and destained in 1% acetic acid. The gels destained or stained for enzyme activity bands
were sandwiched with cellophane sheets and the resultant dried films were kept. The elec-
trophoretic patterns were analysed by a scanning densitometer (Joko Sangyo Co.) in the labor-
atory after comming back to Japan, and the densitometric data were further analysed by a
computor. In a similar way, detection of enzyme activity band(s) was tried for LDH,
LAP, AlkP, and esterases. Peroxidase activity of Hb associated with benzidine-nitroprusside
staining (Ogita, personal communication) was utilized for determining haptoglobin (Hp)
types of individuals.
Detection of Antimalarial Drugs from Urine Samples. After the chemotherapy with
an antimalarial drug, about 50-75 ml of fresh urine samples of patients were extracted
with chloroform after alkalification with a cone. NaOH solution. The chloroform-extractable
fraction was washed by a diluted NaOH solution and chloroform was evaporated in air. The
organo-soluble residue was then analysed by thin-layer chromatography on a pre-coated TLC
silica gel plate (E. Merck) in an empty instant coffee bottle. A solvent system employed
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was methanol-acetic acid-water (4: 5: 1 or 4: 6: 1, v/v). Another solvent system of
chloroform-acetic acid-water (1: 6: 1) was also employed in some cases. For detecting
chloroquine or amodiaquine on a TLC plate, Dragendorff reagent was sprayed after ascending
chromatography about 7-9 cm. For detecting sulfamethopyrazine, Ehrlich reagent was used.
RESULTS AND DISCUSSION
I . Quantitative Analysis of Blood Biochemical Levels
As mentioned above, comparison on quantitative data on some biochemical examination
was made on admission day to the hospital (namely, just before starting the chemotherapy for
malaria) and on discharge day from the hospital (namely, after completion of the chemother-
apy and the subsequent follow-up). Table 2 summerizes plasma levels of various items (ex-
cept for Hb test where a whole blood sample was used in the analysis). At first, much
more patients were subjected for these examinations, but during the course of the follow-up,
unnegligible numbers of patients were omitted from the counts by various reasons, such as
recrudescence of parasitemia (resistant cases), transfer of colonists to other subcolony or
colony, release from the colony (completion of the sentence), and so on. The final number
of the falciparum case was 23, among them 17 were treated with chloroquine and 6 were
with sulfamethopyrazine. Although the final number of subjects was too small, there were
no remarkable difference in blood biochemical data between these drug groups or between
vivax and falciparum cases.
Biochemical reagents to be used for blood examination are usually requested to be
stored in the dark and cold place such as in a refrigerator, and under the usual laboratory
condition there is no difficulty to do so. In a field medical research at a rural area of the
tropical zone, however, it is rather impossible to find out an appropriate cold room to keep
Table 2. Comparison of plasma biochemical levels (average and range) between data
of pre- and post-chemotherapeutic treatments
Items m FalCiP(23USsS)laria Vivax malaria <30 cases) Normal control (10 cases)
tested m Before After Before After First Two weeks
treatment treatment treatment treatment examination later
Hb* g/dl
TP g/dl
Alb g/dl
BUN mg/dl
ZTT Kunkel
12.8 13.5
(-9.4-15.6) (10.8-15.2)
7.0 7.4
(5.6-7.7) (6.4-8.6)
4.1 4.5
(2.3-5.2) (3.5-5.1)
31.1 26.6
(25.1-40.1) (22.6-29.2)
2.8 3.5
(1.7-4.3) (1.8-5.8)
426 326
LDH Wroblewski (200-730) (150-520)
GOT Karmen
GPT Karmen
22 18
(12-47) ( 9-49)
24 17
(12-74) (12-35)
13.3 13.8
(8.1-15.5) (6.8-15.6)
7.0 7.4
(5.9-8,3) (5.9-8.0)
3.9 4.4
(2.6-5.2) (3.6-5.8)
29.7 28.0
(22.8-36.8) (22.7-31.5)
3.0 3.5
(1.2-4.5) (2.4-5.2)
380 256
(120 -820) (120 -420)
28 21
(10-89) (10-49)
24 21
( 8-90) (14-53)
15.5 15.2
(12.9-17.9) (13.2-16.9)
7.4 7.3
(6.8-8.2) (6.9-8.0)
5.1 4.9
(4.5-5.7) (4.4-5.3)
24.0 27.7
(20.7-29.5) (25.1-29.8)
1.9 2.2
(0.8-3.0) (1.0-3.5)
161 201
(220- 380) (180-320)
15 16
(12-18) ( 8-26)
20 16
(ll-37) (13-22)
Whole blood samples were used exceptionally for the Hb test.
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l arge quantities of chemical reagents for several months. Therefore, some simulation tests
were also performed in our laboratory, Nagasaki University, to examine whether or not these
chemical reagents could be stored at tropical room temperature. A group of chemical rea-
gents was kept in a could room at 3-8°C as usual, and the other in an incubator adjustedto
30°C. Blood examinations of healthy subjects (members of the team) were carried out at
various intervals by using reagents of both groups. Contrary to our initial expectation, no
remarkable difference was observed between data obtained by using reagents of these groups
when the original seal of the reagents was kept unopened up to 5 months. Exceptions
were the cases of LAP and AlkP, where the data examined by chemicals kept at 30°C al-
ways gave us higher measurements than those in the control groups. The data for LAP and
AlkP are thus omitted from Table 2.
II. Clinical Examination of Urine
Urine samples of patients were also examined for pH, protein, sugar, Hb, bilirubin
and urobilinogen. Practically no alteration was observed in urine pH, and all the pa-
tients showed negative results in the glucosuria and hematuria tests. Of 45 patients whose
urine gave positive results in the urobilinogen test on admission, 31 subjects showed im-
proved changes in urobilinogen test after the chemotherapy (16 of 26 urobilinogen test positive
patients in vivax malaria, and 15 of 19 positive tests in falciparum malaria). Similar improve-
ments were observed in the urine protein test: of 36 positive subjects 29 showed improved
results (18 of 21 in vivax cases and ll of 15 in falciparum cases). Table 3 presents compar-
isons of actual data for urine protein and urobilinogen between pre- and post-chemotherapy
tests. It is quite obvious that the distribution patterns have shifted towards negative in
accordance with symptomatic improvement of these patients.
III. Electrophoretic Analysis of Plasma Proteins
Comparisons in electrophoretic patterns of proteins were carried out between plasma
samples taken from the same individuals just before and after the chemotherapy. Human
blood plasma (or serum) is composed of a number of proteins and separable into several
amido-black stainable bands after electrophoresis (Fig. 2).
Prealbumin: Normal range of prealbumin is quite lower than that of other major plasma
T able 3. Alteration of protein and urobilinogen levels in urine samples of malaria
patients after chemotheranv fexpressed as number of patients^)
P i ,. ,. , Falciparum malaria Vivax malaria
OOlOl LcHL s-ir\ \ snf\ N(19 cases) (30 cases)
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p roteins, and the separation of prealbumin from albumin is not achieved by usual cellulose
acetate electrophoresis. These are major reasons why quantitative variation of prealbumin
has often been ignored in routine clinical examinations. In the present work, however, an
increase in prealbumin level after the antimalarial treatment (and the subsequent follow-up for
two weeks) was evidently noticed by polyacrylamide gel electrophoresis of plasma samples in
almost all the malaria patients. This was further confirmed by scanning densitometry (Fig.
2) : namely, in the first examination just before starting the chemotherapy, an average pre-
albumin level was 22.5 mg/dl (range, 16-39 mg/dl) in 13 falciparum cases, and 16.2 mg/dl
(range, 6-40 mg/dl) in 15 vivax cases. After the chemotherapy, on the other hand, the
average levels increased to 31.2 mg/dl (range, 22-44 mg/dl) in falciparum malaria, and to
27.4 mg/dl (range, 15-40 mg/dl) in vivax malaria, respectively. These increases in pre-
albumin level after chemotherapy were statistically highly significant. As far as we know,
the decrease in prealbumin level has not been reported in connection with malaria. Although
the present observations are not based on experimental infections, and although it is not sure
whether or not such an increase in prealbumin level is a temporary phenomenon after the cure
from severe symptoms of malaria, it might be said that the decrease in prealbumin level is
one of the characteristic phenomena in human malaria.
Ref ore
chemotherapy
Tf
Pa/
H-^ Alb
%
*
o ^ -
G
u
»
*
Two weeks
later *
Falciparum Malaria Patient
(No. H-273 )
Vivax Malaria Patient
( No. H-176)
Electrophoretic comparison between plasma protein patterns before and
after the chemotherapy in the same patients. Note the increase or
decrease in some protein fractions indicated by solid arrows.
Pa: prealbumin, Alb: albumin, Tf: transferrin, U: unidentified,
G: gamma-globulin zone, and O: origin.
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Prealbumin is known as a carrier of thyroid hormones and of vitamin A (Kanai
et al., 1968; Raz et al., 1969). Thus the increase in prealbumin level of the malaria
patients after the chemotherapy might reflect the accelerated rate of general metabolism after
the recovery from the severe illness.
Unidentified Protein Band: In most falciparum cases, quantitative alterations of an uniden-
tified protein fraction with a slightly slower electrophoretic mobility than transferrin were ob-
served ; namely, electrophoretic patterns showed a rather high level of this fraction in plasma
taken from patients before the chemotherapy whereas this protein decreased after the drug
treatment. In vivax malaria, on the other hand, such a decrease in this protein was observed
among only a half of the patients, and this protein fraction still remained high among the
other half of the vivax patients even after cure of the malaria. At present it is not yet clear
whether this change is characteristic to the falciparum cases or has occurred by chance.
The protein itself is, in some cases, recognizable even in fresh plasma samples, and
hence such an alteration in this protein region may not be due to a "storage effect" such as
a change of $ic-globulin to /3iA-globulin, whereas the electrophoretic position of this pro-
tein band is still suspicious enough to lead a temporary identification as /3iA-globulin frac-
tion. If this is the case, the reason is still unknown why the different results have been ob-
tained between these two malarial groups. /3ic-globulin or the third component of comple-
ment (C3) is easily converted into a series of conversion products, among which /3i,A-
globulin (C3c) is the major one, and this conversion is related to immune hemolysis. In
connection with malaria, Dulaney (1948) reported decreased complement contents in induced
malaria patients, whereas Cameron and Kibukamusoke (1971) could not show statistically
significant differences in C3 levels between malariae malaria patients and controls. One of
another possibility for the identification of this unknown protein is one of the Hb-Hp complex
bands. It is well known that Hb easily binds to Hp and forms several kinds of Hb-Hp com-
plexes of which electrophoretic mobilities are different from each other or from that of un-
bound Hp molecule. The electrophoretic behaviour of the Hb-Hp 1- 1 band is sometimes similar
to that of the protein band in question, and it is also known that the mobility of the Hb-
Hb complex bands is changeable in accordance with the degree of saturation with Hb
(Ogawa et al., 1968). Thus the possibility that this unidentified protein band is an inter-
mediate Hb-Hp complex still cannot be neglected.
Gamma-globulins : Increasing levels in gamma-globulin zones were observed in accordance
with results by other investigators (Fig. 2, Table 1).
Haptoglobin Type: In the case of malaria patients, severe hemolysis occurs in the blood
stream in accordance with the life cycle of erythrocytic forms of malaria parasites, and in
spite of a scavengering activity by Hp, excess amounts of Hb or its related complexes or de-
gradation products might be one of the major causes of clinical symptoms. It is also known
that 2-2 type Hp binds less Hb than Hp 1-1 or Hp 1-2 (Curtain et a/., 1965), and a se-
lective advantage of Hp1 gene in malarious tropical areas is still an attractive explanation,
although they could not find any significant difference in Hb type distribution between
malaria parasite positive and negative groups. For these reasons, Hp has attracted our
attention, too; then blood samples of some malaria patients were examinied for Hp typing by
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electrophoresis.
Out of 34 malaria patients examined, 4 belonged to Hp 1-1 type, 8 were Hp 1-2
type, and 8 were Hp 2-2 type. However, another 14 could not be identified because of
absent or faint Hp band. In the case of healthy persons as controls, Hb-Hp patterns were
quite typical and hence Hp type of individuals could be easily deternimed. Among Filipino
populations, Blackwell et al.(1963) reported Hp type distribution and the frequency of Hp1
gene was 0.38. Similar results on the distribution of Hp types (the gene frequency of Hp1 :
0.41) and difficulty in identifying Hp types among pathologic subjects were also shown by
Bayani-Sioson (1968) in 473 normal and 109 patients of the Filipinos, whereas no malaria
case was included in her report. Concomitant decreases in Hb and Hp levels were demon-
strated by Blumberg et a/.(1963) during the course of experimental infection of malaria to
volunteers. Murphy et al.(1972) reported that a decrease in o^-glycoprotein in malaria was
mainly due to a decrease in Hp. The present study confirmes the decrease in Hp in malar-
ia patients more directly.
LDH: It has been mentioned in earlier part of the present paper and in Table 2 that plasma
LDH levels of malaria patients are sometimes extremely high in spite of the greatest possible
caution to prevent or minimize technical hemolysis of erythrocytes (RBC) after blood taking.
By electrophoresis the LDH enzyme can be separated usually into 5 isoenzyme bands. There-
fore it may be possible to know by examining the isoenzyme pattern whether such an abnor-
mally high LDH level in plasma of malaria patients is accountable for possible hepatic lesions
or for severe disintegration of RBC by malaria parasites in blood stream. Relative color
intensity of LDH isoenzymes after nitro bule tetrazolium-staining in normal plasma is :
LDH-2 > LDH-3 > LDH-1 > LDH-4 > LDH-5
and the isoenzyme pattern of normal hemolysates is :
LDH-1 > LDH-2 > LDH-3 > LDH-4> LDH-5.
In the cases of plasma of malaria patients, on the other hand, the increase in LDH-1 iso-
enzyme activity was significant, and the order of the color intensity is :
LDH-1 ^LDH-2 > LDH-3 > LDH-4 > LDH-5.
These findings evidently indicate that the increased level of LDH-1 band in malaria patients
is originated mainly from the disintegration of RBC but not from that of liver cells. In some
cases, of course, the LDH patterns were indicative of the presence of some hepatic lesion,
but the intensity of LDH-2 or LDH-1 band was far superior to that of other isoenzyme
bands.
Presence of an extra LDH isoenzyme band of the parasitic origin was not observed in
plasma of malaria patients over the period of the present field survey whereas in the case of
a rodent malaria an extra LDH isoenzyme band was detected in plasma of malaria-infected mice
(Tsukamoto, 1974). Carter and McGregor (1973) reported that some human blood samples
infected with P. falciparum showed the presence of additional 3 enzyme bands of the para-
sitic origin other than usual human LDH patterns. They did not mentioned, unfortunately,
whether the parasite enzyme bands were found in patient's plasma or hemolysates.
Miscellanea : In parallel with works on the protein pattern, electrophoretic analysis of
so-called "non-specific" esterases, LAP, and AlkP activity bands was also attempted. No
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remarkable or unique pattern was observed in comparison of plasma between normal and
malarial individuals, between falciparum and vivax patients, or between pre- and post-chemo-
therapeutic samples.
IV. Detection of Antimalarial Drugs from Urine Samples after Chemotherapy
Several cases of drug-resistant malaria have been experienced in the research area
during the period of the present survey as previously reported (Nakabayashi et al. , 1974).
Apart from genetic character of the malaria parasites, slow and low absorption or rapid
excretion of an orally administrated antimalarial drug by patients might also be one of suspi-
cious causes for so-called "drug-resistance". In more extreme case, the treated amount of
drug is not absorbed physiologically or psychologically (for example, by vomitting the
tablets) into the patient's blood stream and the oral treatment with an antimalarial drug does
not show any curative effect; thus in such a case a physician might easily be misled to be
as if a "drug-resistance" case. Actually, we have also had such experiences with some ma-
laria patients. Therefore, attempts were made to detect a given drug from patients' blood or
urine samples. After extraction of drug (and its metabolites, if any) from biological samples
with chloroform, the organo-soluble residue was analysed by ascending chromatography using
a pre-coated silica gel G plate. Chloroform was chosen as an extracting solvent in field
works because of its non-inflammability, high volatility, easy availability, multi-purpose usabi-
lity as an anesthetic for mosquito examinations or as a developing solvent in thin-layer chro-
matography, and so on.
From blood samples, the detection of chloroquine or amodiaquine was not successful at
various time intervals after the oral radical treatment. On the other hand, the administrated
drug was easily detected from urine samples even 2 hours after the oral treatment, suggest-
ing that some parts of the drug are rapidly absorbed into patient's blood system and soon
excreted into the urine. Usually, even up to 7 or 10 days after the radical treatment with
chloroquine or amodiaquine, the presence of relatively large amounts of the drug could be
easily detected from urine samples by TLC. Thus, a possible misleading due to no or poor
absoption can be exculded from so-called "drug-resistance" cases in malaria by employing
such a simple TLC method in field.
CONCLUSIONS
From the results obtained from such preliminary field works, it is rather inadequate to
draw any definite or precise conclusions on clinical-biochemical data as being expected in a
well-facilitated laboratory. It has been demonstrated, however, that such blood analysis are
not only possible even in field but also effective for well-understanding patients' conditions of
illness during the course of therapy and follow-up.
In tropical zones, except for urban or suburban areas, availabilities in electricity, wa-
ter supply and transportation are usually quite limited. Such inconveniences might be over-
cometo a certain extent by using a portable generator, ice-box, kerosene- or propane-operated
refrigerator, and so on. Recent development of handy clinical examination kits made it pos-
sible to carry out blood examination easily in field. In such cases most of the chemical rea-
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gents are requested to be stored in a cold place, and this seemed to cause a difficulty
in practical application in field works. Results of the present paper, however, suggest that
even without a cold room or a large refrigerator such a clinical blood analysis can be done on
many items which are most commonly employed in usual clinical laboratories. Results on
some of enzyme tests, for example LAP and AlkP, have been omitted in the present paper,
because they gave us abnormally higher values after storage at tropical room temperature for
few months. It might be, however, possible to estimate adequate values by adjusting data
from a calibration curve, or by improving constituents of the chemical reagents in future.
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フィリピン・パラワン島辺地におけるマラリア患者血液の臨床生化学的検査
塚本増久,山口恵三,常多勝巳,中林敏夫(長崎大学熱帯医学研究所疫学部門)
1971年から1973年にかけてフィリピン・パラワン島イワヒグ地区においてマラリア患者の化学療法
とクロロキン耐性についての研究を行なったが,その際患者の血液(および一部尿についても)の臨
床生化学的検査を試みた.当地区は電気,水道,ガスなどの設備のない辺地であるが,携帯用の小型
発電機や灯油冷蔵庫などを利用することにより有用な知見を得ることが出来たので,その結果の概略
について報告する.抗マラリア剤(主としてクロロキン)投与による同一マラリア患者について,通
常治療前および治癒後の2回静脈血を採取し,血漿分離後種々の検査成績について比較した.治療前
には,三日熱・熱帯熱いずれの場合にも総蛋白,アルブミンなどの量が低下していたが,治癒後増加
が見られた.また,乳酸脱水素酵素(LDH),アスパラギン酸アミノ転移酵素(GOT),アラニ
ンアミン転移酵素(GPT)などの活性値はマラリア患者血漿では高い者が多かったが,治癒後は低
下した.ポリアクリルアミドゲル平板による患者血漿の電気泳動ではプレアルブミン量が低かった
が,治癒後殆んど全部の患者で増加が認められた.ブレアルブミンはビタミンAや甲状腺ホルモンの
担体として知られているので,マラリア治癒後の体内での活発な代謝促進を反映しているものと解釈
できる.また患者血漿中にはトランスフェリンよりやや泳動度の低い未同定の蛋白バンドがあるが,
熱帯熱マラリアの場合には治癒後減少する傾向が認められたのに対し,三日熱マラリアの場合は治癒
の前後とこの蛋白量の増減との間に一定の関係は見られなかった.マラリア患者では上記の如く血漿
LDH活性値が異常に高い者が多いが,その原因を知るための電気泳動によるアイソザイム分析の結
果,肝臓障害由来と考えるよりはむしろマラリア感染による赤血球の著しい溶血に由来するものであ
ると判断された.患者の症状の軽重とハプトグロビン(Hp)型との関係の有無を知る目的で予備的調
査を行なったが,マラリア患者では型判定の困難な場合が多かった.これも多量の溶血に伴なうHp
の血流中での著しい減少に基づくものと解釈すれば説明がつけられる.血液以外にも患者尿について
いくつかの検査が行なわれたが,蛋白やウロビリノーゲンなどの量は治癒後有意に減少することが示
された.また経口投与後のクロロキンは, 2�"3時間から1週間にわたって患者尿中から薄層クロマ
トグラフィーで容易に検出されたが,血液中からの検出は困難であった.
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